Home

Fusione Scoperta Libreria nejm clinical videos Disordinato spiegare bangio

Effectiveness of Covid-19 Vaccine in Adolescents | NEJM
Effectiveness of Covid-19 Vaccine in Adolescents | NEJM

TCR Gene Therapy in Pancreatic Cancer | NEJM
TCR Gene Therapy in Pancreatic Cancer | NEJM

BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children | NEJM
BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children | NEJM

CT in Stable Chest Pain | NEJM
CT in Stable Chest Pain | NEJM

Clinical Examination of the Hip | NEJM
Clinical Examination of the Hip | NEJM

Once-Weekly Tirzepatide for Obesity | NEJM
Once-Weekly Tirzepatide for Obesity | NEJM

Empagliflozin in HF with Preserved Ejection Fraction | NEJM
Empagliflozin in HF with Preserved Ejection Fraction | NEJM

Fourth Dose of BNT162b2 Covid-19 Vaccine | NEJM
Fourth Dose of BNT162b2 Covid-19 Vaccine | NEJM

Respiratory Syncytial Virus Vaccine Study | NEJM
Respiratory Syncytial Virus Vaccine Study | NEJM

Time-Restricted Eating for Weight Loss | NEJM
Time-Restricted Eating for Weight Loss | NEJM

Angiotensin Receptor–Neprilysin Inhibition in Acute MI | NEJM
Angiotensin Receptor–Neprilysin Inhibition in Acute MI | NEJM

Tranexamic Acid in Noncardiac Surgery | NEJM
Tranexamic Acid in Noncardiac Surgery | NEJM

NEJM Group - YouTube
NEJM Group - YouTube

Clinical Features of VITT | NEJM
Clinical Features of VITT | NEJM

Hepatopulmonary Syndrome | NEJM
Hepatopulmonary Syndrome | NEJM

Oncolytic Virus for Pediatric Pontine Glioma | NEJM
Oncolytic Virus for Pediatric Pontine Glioma | NEJM

Phase 1–2 Trial of Gene Therapy for Hemophilia B | NEJM
Phase 1–2 Trial of Gene Therapy for Hemophilia B | NEJM

Monoclonal-Antibody Combination to Prevent Covid-19 | NEJM
Monoclonal-Antibody Combination to Prevent Covid-19 | NEJM

Early Ivermectin for Covid-19 | NEJM
Early Ivermectin for Covid-19 | NEJM

Lenacapavir in Multidrug-Resistant HIV-1 Infection | NEJM
Lenacapavir in Multidrug-Resistant HIV-1 Infection | NEJM

Convalescent Plasma for Covid-19 in Outpatients | NEJM
Convalescent Plasma for Covid-19 in Outpatients | NEJM

Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM
Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM

Surgery articles: The New England Journal of Medicine
Surgery articles: The New England Journal of Medicine